Skip to main content
OpenTrials
Completed

NCT Number: NCT01911208

A Randomized Recruitment Intervention Trial

The purpose of this study is to test a recruitment intervention to increase racial and ethnic diversity in clinical trials. The trial will be conducted in specialty care clinics. In RECRUIT minorities are those underrepresented in clinical trials and include:

* African Americans/ Blacks * Asians * Native Hawaiians/Other Pacific Islanders * Hispanic/Latinos * Native Americans/Alaskan Natives

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Texas Health Science Center School of Public Health

Houston, Texas, 77030, United States

About this study

Low minority participation in clinical trials limits our ability to assess and address potential differences in therapeutic responses. To address the problem of low minority recruitment we are initiating a randomized trial of a recruitment intervention (RECRUIT) funded by the National Institute on Minority Health and Health disparities (NIMHD) to increase racial/ethnic diversity in clinical trials.

Our specific approach is directed toward multi-site trials conducted at specialty clinics within academic centers with recruiting venues that include community practices or practices of colleagues in other areas of the academic center. The intervention will focus on approximately 60 specialty clinics. Clinical sites will be randomized to the intervention or control group. The target of the intervention will be the site investigators and clinical trial coordinators.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion:

A parent trial must :

  • have a coordinating Center willing to allow their Clinical Sites to participate;
  • be studying be studying a condition that requires community or health system physician referral
  • be studying an intervention where the recruitment approach cannot be made directly to minority community members
  • need to increase recruitment of racially/ethnically diverse participants* to the trial as demonstrated by current trial progress or historical data from other trials in the same disease;
  • be a Phase II or Phase III trial
  • be conducted in at least six multiple sites;
  • expect each Clinical Site to recruit at least 10 participants;
  • be funded by a sponsor (NIH or pharmaceutical company or other) that has a strong commitment to recruiting racially/ethnically diverse subjects;
  • be willing to have investigators and coordinators attend a special training meeting (at RECRUIT expense);
  • require randomization to intervention or control (could be best medical care or active control or placebo or other type of control);
  • provide transportation costs for trial participants who need assistance in getting to trial sites or use some RECRUIT reimbursement for this purpose.

The clinical site must

  • be a funded Clinical Site in the parent trial;
  • be located in an area where at least 20% of the population within 30 miles in the age group under study in the parent trial are from diverse populations.

Exclusion criteria

  • site does not agree to be randomized;
  • investigator or coordinator is under 18 years of age.

Treatment and study plan

RECRUIT intervention

Behavioral

Sites randomized to RECRUIT are taught skills to develop a tailored recruitment intervention encompassing continuous quality improvement and patient navigation.

Control

Behavioral

Non-intervention control.

Primary outcomes

  1. Percentage of racially/ethnically diverse participants (minorities) enrolled

    Time frame: Up to 2 years

    Minorities as defined in this trial include those underrepresented in clinical trials and considered underrepresented by NIH criteria with the addition of those of Asian descent.

Secondary outcomes

  1. Number of participant referrals

    Time frame: up to 2 years

    Differences between intervention and control sites in number of participant referrals.

  2. Recruitment Activities

    Time frame: up to 2 years

    Numbers and types of activities reported on recruitment logs by all sites.

  3. Investigator and Coordinator Outcome expectations

    Time frame: up to 2 years

    Change from baseline in physician investigator and coordinator outcome expectations (intervention sites only).

  4. Qualitative Key Informant Interviews

    Time frame: up to 2 years

    Qualitative key informant phone interviews of the physician investigators and coordinators (intervention and control sites).

  5. Participant Satisfaction

    Time frame: up to 2 years

    Potential/enrolled participant satisfaction with intervention and control trial site investigators and coordinators. Subjects will be given a satisfaction survey at screening and at every follow up visit.

  6. Investigator and Coordinator Self-Efficacy

    Time frame: up to 2 years

    Change from baseline in physician investigator and coordinator self-efficacy(intervention sites only).

Sponsors and collaborators

Lead sponsor

The University of Texas Health Science Center, Houston

Other

Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

Registry information

Acronym: RECRUIT

Important dates

Study start
2011
Primary completion
2017
Study completion
2017
First posted
Jul 30, 2013
Registry last updated
Jun 29, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.